Article Text

Download PDFPDF
What are the consequences of cancer on the return to work among French military personnel?
  1. Guillaume Vanderperre1,
  2. M Lalande1,
  3. O Bylicki1,
  4. D Delarbre1,
  5. C Verret2,
  6. C Helissey3,
  7. M Marcaillou1,
  8. A-R Bronstein1,
  9. M Patient4,
  10. E Romeo4,
  11. J-S Bladé1 and
  12. L Boudin4
  1. 1Military Teaching Hospital Sainte Anne, Toulon Armees, France
  2. 2Bureau Recherche, Direction de la Formation, de la Recherche et de l'Innovation, Paris Cedex 05, UK
  3. 3Hôpital d'Instructions des Armées Bégin, Saint Mande, France
  4. 4Department of Oncology and Haematology, Military Teaching Hospital Sainte Anne, Toulon Armees, France
  1. Correspondence to Dr Guillaume Vanderperre, Military Teaching Hospital Sainte Anne, Toulon Armees 83000, France; gui.vanderperre{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Fighting cancer is a public health priority owing to its high incidence. In Europe, three million new cancer cases and nearly two million cancer-related deaths are reported annually.1 Therapeutic innovation in oncology has led to a gain in survival for patients. This has resulted in an increase in the number of long survivors for whom quality of life is a major focus. Maintaining employment and returning to an active life contribute to the quality of life and are sources of stress for patients, as up to 50% of them lose or leave their jobs due to cancer.2

The military population is different compared with the general population (younger, working in extreme conditions, requiring more medical monitoring, have a lower mortality rate and have a different nature than that of the general …

View Full Text


  • GV and ML contributed equally.

  • Contributors GV and LB drafted the manuscript; ML collected the data; OB analysed the data, LB received the funding for this study, all the authors helped with the draft; CV and LB have administrative or logistic support for this review; all the authors agreed with the conclusions of this review; and all authors read and approved the final manuscript.

  • Funding This study received funding from the Department of Training, Research and Innovation of the French Armed Forces Health Service, number 2021HJ10.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.